Are NAD+ supplements actually worth it?

By Kokei Abam, RDN · Registered Dietitian Nutritionist

Published June 2, 2026 · Last reviewed June 2, 2026 · 9 min read

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme essential to cellular energy production, metabolic regulation, and DNA repair. NMN and NR are NAD+ precursors that increase NAD+ concentrations in humans, but current evidence does not consistently demonstrate meaningful improvements in clinical or functional outcomes. Their value is best evaluated through the broader lens of safety, cost, and the strength of supporting evidence.

What NAD+ Is and What It Does in the Body

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme required for cellular energy production and DNA repair. It supports mitochondrial energy production through redox reactions and also participates in cellular regulation through non-redox functions involving gene expression and stress response. These roles in cellular metabolism are maintained through continuous synthesis of NAD+ from precursor compounds, including NMN and NR, through established metabolic pathways.

At the cellular level, NAD+ supports mitochondrial function, DNA repair, and cellular signaling through enzymes such as sirtuins and poly(ADP-ribose) polymerases, which regulate cellular responses to damage and metabolic demand. Amjad et al. (2021) described these processes as central to cellular maintenance and metabolic regulation.¹

NAD+ levels decline with age in human tissues, a change Chini et al. (2017) associates with reduced mitochondrial efficiency and altered cellular repair capacity.² This decline has been linked to age-related physiological changes, making NAD+ relevant to research on whether restoring its levels through supplementation may influence human health outcomes, although this remains under investigation.

What NAD+ Supplements Are and How They Work

NAD+ supplements do not contain NAD+ directly; instead, they supply precursor compounds, primarily nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR), which are converted within cells into NAD+ through endogenous salvage pathways, thereby increasing intracellular NAD+ availability rather than replacing the coenzyme itself.

NMN and NR Overview

NMN and NR are the most studied NAD+ precursor compounds in human research. They occur naturally in small amounts in foods such as meat, milk, and vegetables and can also be produced by microorganisms in fermented foods. Both contribute to NAD+ biosynthesis and support intracellular NAD+ pools through established metabolic pathways.

As Alegre et al. (2023) describe, interest in NMN and NR is grounded in the central role of NAD+ as a redox cofactor and signaling molecule involved in energy metabolism, cellular stress responses, and genomic maintenance.³ NAD+ levels and biosynthesis are reported to decline under metabolic stress and in some tissues with aging, which has driven research into dietary precursors that may support NAD+ availability.

Current research examines NMN and NR as dietary precursors within NAD+ metabolic pathways, with ongoing investigation into their bioavailability, physiological effects, and dietary contribution, including interactions with gut microbiota.

Conversion Pathway

NMN and NR do not provide NAD+ directly. Instead, they are converted into NAD+ through endogenous salvage pathways that regulate intracellular NAD+ synthesis. NR is converted to NMN, which is then used to generate NAD+, integrating into established cellular metabolic routes described by Yang et al. (2020).⁴ These pathway differences contribute to variability in how efficiently different tissues utilize NAD+ precursors.

Supplement Types

NAD+ supplementation is primarily based on precursor compounds, most commonly:

1. nicotinamide riboside (NR),
2. nicotinamide mononucleotide (NMN), and
3. combinations such as NR with pterostilbene.

These are often formulated as oral capsules or powders, with a smaller number of sublingual products designed for oral absorption. Intravenous NAD+ is also offered in select wellness settings as a separate delivery format outside standard supplement formulations.

What Human Research Actually Shows

Human studies consistently show that NAD+ precursor supplements such as nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) increase NAD+ levels in blood, with some studies also demonstrating measurable increases in skeletal muscle and other tissues. However, these biochemical changes have not translated into consistent or established improvements in energy, aging-related outcomes, or overall health.

Randomized controlled trials suggest that any functional effects may be context-dependent. Liao et al. (2021) found that NMN supplementation improved certain measures of aerobic efficiency during exercise training in recreational runners, including oxygen uptake at submaximal thresholds, though maximal oxygen capacity and peak performance did not differ significantly from placebo.⁵ Yoshino et al. (2021) similarly demonstrated improved insulin-stimulated glucose uptake and enhanced muscle insulin signaling in overweight and prediabetic postmenopausal women, indicating measurable metabolic effects without establishing long-term clinical benefit.

In healthy individuals, however, findings have been less convincing. Campelj et al. (2022) report that NR and NMN do not consistently improve skeletal muscle adaptation or athletic performance, suggesting that benefits may be more likely in states of NAD+ deficiency or metabolic impairment.⁶ Christen et al. (2026) confirmed that both NMN and NR increase systemic NAD+ concentrations in healthy adults, while identifying gut-mediated metabolic differences that may contribute to variability in individual response.⁷

More targeted clinical applications are also being explored, with Bohr et al. (2026) describing early evidence that NAD+ precursors may support DNA repair capacity and mitochondrial function in rare disorders involving premature aging and DNA repair dysfunction, although these findings remain specific to select disease contexts and cannot be generalized to routine supplementation use.⁸

Laboratory and Animal Research

Preclinical studies provide much of the biological rationale behind NAD+ supplementation. In laboratory and animal models, restoring NAD+ levels has been shown to influence cellular pathways involved in energy metabolism, DNA repair, oxidative stress, and aging, but these findings demonstrate potential mechanisms rather than confirming that the same effects occur in humans.

Lautrup et al. (2024) described NAD+ as a central regulator of mitochondrial energy production, DNA repair, autophagy, inflammation, and neuronal function, with reduced NAD+ linked to multiple hallmarks of aging in experimental models.⁹ In cell-based research, Nakajo et al. (2023) found that NMN reduced oxidative stress-induced cellular damage through activation of the SIRT1/NQO-1 pathway, supporting a possible role in cellular stress resistance.¹⁰

Animal studies have also shown functional effects. Kiss et al. (2019) reported that NMN restored angiogenic function and reduced oxidative stress in aged vascular cells,¹¹ while Reiten et al. (2021) and Csiszar et al. (2019) describe consistent evidence that NAD+ restoration can improve metabolic and vascular function and support cellular resilience in models of age-related decline.^12,13

These findings establish a plausible biological basis for NAD+ supplementation and help explain its relevance to aging research. However, preclinical evidence cannot confirm comparable clinical benefits in humans, and effects observed under controlled experimental conditions do not always translate into measurable health outcomes in people.

Human Research

Human clinical studies consistently show that NAD+ precursor supplements can increase NAD+ levels in blood and, in some cases, within specific tissues. Across trials involving NMN, NR, and related compounds, supplementation reliably raises NAD+ concentrations, confirming that these products can influence the biological target they are designed to affect.¹⁴

The more difficult question is what those biochemical changes actually mean for health. Although some studies report measurable functional improvements, the results remain selective and often modest. Blanco-Vaca et al. (2022) describe improvements in outcomes such as exercise capacity, blood pressure, inflammatory markers, and insulin-stimulated glucose disposal in certain populations, but note that these effects have not consistently extended to harder clinical endpoints such as meaningful changes in body weight or long-term metabolic disease markers.¹⁵

A meta-analysis by Zhong et al. (2022) similarly found that NAD+ precursor supplementation improved triglyceride, total cholesterol, LDL, and HDL levels in humans, but also identified an increase in plasma glucose, adding important context to claims of cardiometabolic benefit.¹⁶ Gindri et al. (2024) also report benefits in specific settings, including improved muscle insulin sensitivity and changes in quality-of-life measures, though the relevance of these findings across different populations remains uncertain.¹⁷

A major limitation of the current evidence is study design. Many human trials are small, involve highly specific populations, and last only weeks to a few months, making it difficult to assess whether short-term increases in NAD+ can produce durable health effects. Wide variation in dosing strategies, participant characteristics, and study duration has been identified as a major barrier to drawing firm conclusions,¹⁴ while clinical efficacy in humans has been more limited than early preclinical findings suggested.¹⁸

This distinction is central to interpreting the evidence: raising NAD+ is a measurable biological outcome, but improved NAD+ levels do not automatically translate into improved health. Current human research supports the ability of these supplements to increase NAD+ availability, but longer and more rigorous studies are still needed to determine when, for whom, and to what extent those biochemical changes lead to meaningful clinical benefit.

Cost vs Evidence: Are NAD+ Supplements Worth the Price?

The cost of NAD+ supplements is relatively high, while evidence for consistent clinical benefit in humans remains limited. Value depends on how uncertain biological effects are weighed against financial cost and expected outcomes.

Oral NAD+ precursors such as nicotinamide riboside and nicotinamide mononucleotide typically range from about $30 to over $150 per month, depending on dose, formulation, and brand. Intravenous NAD+ therapy is substantially more expensive, with per-session costs often ranging from $250 to over $1,000 in private clinical or wellness settings, with repeated use increasing total expenditure over time.

Human studies show that NAD+ precursors increase NAD+ concentrations in blood and selected tissues, confirming biological activity of these compounds. However, Freeberg et al. (2023) and Vinten et al. (2025) reported that clinical outcomes associated with these increases are inconsistent across studies and not reliably demonstrated in general populations.¹⁹

Overall, current evidence does not show a consistent alignment between cost and measurable clinical benefit for most users, making real-world value dependent on individual context and expectations.

How Long It Takes to Affect NAD+ Levels

NAD+ levels can increase within days to weeks in human studies, but these changes reflect biochemical shifts and are not consistently associated with noticeable improvements in energy or performance.

In a phase I pharmacokinetic trial, Berven et al. (2026) reported that blood NAD+ levels increased gradually and plateaued after approximately two weeks of daily nicotinamide riboside or nicotinamide mononucleotide supplementation at 1,200 mg per day. Cerebral NAD+ levels showed measurable increases after about four weeks. NAD-related metabolites rose more rapidly, while NAD+ itself followed slower accumulation and washout kinetics, indicating that sustained daily intake is required to maintain elevated levels.²⁰ The study also observed substantial interindividual variability in response, suggesting differences in timing and magnitude across individuals.

Peluso et al. (2021) note that human data on NAD+ dynamics across tissues remain limited, particularly beyond blood measurements, making it difficult to generalize precise timelines.²¹ Overall, increases in NAD+ can be detected within a few weeks, but corresponding functional effects in humans are not consistently established within the same timeframe.

What People Notice and What They Don't

Most individuals do not experience immediate or noticeable changes when taking NAD+ supplements, despite measurable increases in NAD+ levels.

In human studies, NAD+ precursors reliably increase NAD+ concentrations in blood and selected tissues, but these biochemical changes do not consistently translate into perceived effects such as improved energy, cognition, or physical performance. Reports of subjective improvement exist but are inconsistent across studies and difficult to separate from placebo response. When functional effects have been observed, such as modest improvements in insulin sensitivity or exercise-related parameters, they have typically occurred in specific clinical populations under controlled conditions rather than in generally healthy individuals.

Poljšak et al. (2022) highlight persistent uncertainties in bioavailability, tissue distribution, and pharmacodynamic response, which may help explain the disconnect between measurable NAD+ increases and subjective outcomes, and note that optimal dosing and long-term effects remain insufficiently defined, particularly in healthy populations.²²

Current human evidence indicates that increases in NAD+ are not reliably accompanied by noticeable day-to-day changes in how individuals feel or function.

Safety, Side Effects, and Population Cautions

NAD+ precursors such as NMN and NR appear generally well tolerated in short-term human studies, but long-term safety data remains limited, and caution is warranted in specific populations.

Human clinical trials to date primarily report short-term tolerability, with no consistent signal of serious adverse effects at commonly studied doses. However, safety beyond controlled study durations has not been firmly established.

Concerns have been raised regarding cancer biology, as NAD+ supports DNA repair and cellular energy metabolism. While these processes are essential for normal cellular function, Palmer and Vaccarezza (2021) highlighted theoretical and preclinical considerations suggesting that increased NAD+ availability could also support the metabolic demands of established tumors, underscoring caution in individuals with active or high-risk malignancy.²³

Additional caution applies in pregnancy, lactation, and pediatric populations, where NAD+ is essential for embryonic development and cellular differentiation, yet human supplementation data is absent. Bozon et al. (2025) showed that maternal NAD precursor availability influences embryonic NAD status and developmental outcomes in experimental models, reinforcing the lack of an established safety threshold during early development.²⁴

Drug interaction potential remains incompletely characterized, and NAD+ metabolism is integrated into pathways involved in cellular repair and redox regulation, creating theoretical potential for interactions with medications affecting mitochondrial function, DNA repair, or metabolic signaling. However, clinically confirmed interaction profiles have not yet been established. Persistent gaps in pharmacokinetics, tissue distribution, and long-term metabolic effects remain, particularly under sustained or high-dose supplementation conditions.²²

Short-term use appears biologically tolerable in studied populations, but evidence remains insufficient to define long-term safety, vulnerable populations, or clinically meaningful interaction risks with confidence.

Regulatory Status in the United States

In the United States, NAD+ precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) are regulated as dietary supplements and are not approved as drugs for the treatment or prevention of disease. Regulatory oversight primarily addresses manufacturing quality, product safety, and labeling requirements, with no requirement for pre-market clinical efficacy. NMN, in particular, has faced ongoing regulatory review regarding its eligibility for marketing as a dietary supplement.

NAD+ Supplements Compared With Other Longevity Approaches

NAD+ supplements increase cellular NAD+ availability and influence pathways involved in energy metabolism and cellular repair, but human evidence linking these biochemical changes to consistent health improvements remains limited. By comparison, interventions such as regular physical activity, nutrient-dense dietary patterns, adequate sleep, and effective cardiometabolic risk management demonstrate stronger and more consistent benefits across cardiovascular, metabolic, and functional health outcomes. These foundational approaches act across multiple physiological systems simultaneously, producing measurable and reproducible effects on inflammation, insulin sensitivity, vascular function, and overall metabolic resilience.

For a broader review across the range of compounds promoted for healthy aging, see our overview of evidence-based longevity supplements.

Where NAD+ Supplements Fit in a Broader Health Approach

NAD+ supplements target cellular metabolism through pathways involved in energy production and repair, but translation of these effects into consistent health outcomes in humans remains limited. Physical activity, dietary quality, sleep, and cardiometabolic risk management demonstrate stronger and more consistent evidence for improving energy regulation, metabolic health, and long-term physiological function.

Supplementation with NAD+ precursors reliably increases NAD+ levels, while associated clinical outcomes remain inconsistent.^14,18 Janssens et al. (2022) observed that physically active older adults maintain NAD+ levels comparable to younger individuals, suggesting that lifestyle factors also support the same biological pathways targeted by supplementation.²⁵

Common Misconceptions About NAD+ Supplements

NAD+ supplements are often promoted as fast, reliable interventions for energy and aging, but human research does not support these claims in a consistent or predictable way.

A common misunderstanding is that boosting NAD+ automatically leads to noticeable increases in energy, but human trials have shown that NAD+ levels can rise after supplementation without consistent changes in fatigue, performance, or daily function. Another frequent claim is that NAD+ slows aging, yet current evidence is largely mechanistic, with limited confirmation of meaningful aging-related outcomes in humans.

Speed of effect is also overstated as pharmacokinetics data show that NAD+ levels may increase over days to weeks, but physiological effects, when observed, are variable and not immediate. Finally, higher NAD+ concentrations do not guarantee better outcomes, as response depends on tissue context, baseline physiology, and individual metabolic differences rather than the magnitude of increase alone.

Quality and Supplement Variability

NAD+ supplements vary in precursor type, formulation, and dose, all of which can influence stability, absorption, and biological availability. Common products include nicotinamide riboside, nicotinamide mononucleotide, and combination formulations, which differ in composition and supporting clinical evidence.

Mehmel et al. (2020) note that differences in formulation and bioavailability may affect how efficiently NAD+ precursors are utilized.²⁶ Product quality may also vary across manufacturers, making transparent labeling and third-party testing important considerations for consumers.

Clinical Perspective

Current evidence places NAD+ supplements in a clinically uncertain category: biologically active, increasingly studied, and scientifically plausible, but not yet supported as established interventions for measurable health benefit. Their ability to raise NAD+ levels is well demonstrated, yet consistent improvements in physiological function, disease prevention, or age-related outcomes have not been reliably established in human studies.

Early clinical signals suggest that NAD+ precursors may hold greater relevance in specific contexts, particularly where metabolic dysfunction or impaired NAD+ biology is present. Outside these settings, their role remains exploratory and does not currently support routine clinical recommendation. For now, NAD+ supplementation is best interpreted as a developing area of translational research, with potential that remains ahead of proof.

Bottom Line

NAD+ supplements increase NAD+ levels in humans, but this biochemical change has not been shown to produce consistent or meaningful clinical benefits. The primary effect remains measurable at the biomarker level rather than at the level of health outcomes.

Current evidence does not support NAD+ supplementation as an established intervention for improving health, preventing disease, or modifying aging-related outcomes. Its use remains unsupported in routine clinical practice and should be interpreted within the limits of evolving evidence.

Frequently Asked Questions

Do NAD+ supplements actually work?

They reliably increase NAD+ levels in humans, but there is no consistent evidence that this translates into meaningful improvements in health, energy, or aging outcomes.

Are NMN and NR the same thing?

No. Both are NAD+ precursors, but they are different compounds with different metabolic pathways. Both can raise NAD+ levels, but they are not interchangeable.

How long should NAD+ supplements be taken?

NAD+ levels can rise within 2–4 weeks of continuous use. There is no established clinical guidance on optimal duration of supplementation.

Are NAD+ supplements safe long term?

Short-term studies suggest good tolerability, but long-term safety data in humans remains limited.

Should NAD+ levels be tested before starting?

No. NAD+ testing is not standardized or routinely used in clinical practice and does not currently guide supplementation decisions.

Are there natural ways to increase NAD+?

Yes. Physical activity, sleep quality, and dietary patterns support NAD+ metabolism, and human data suggest lifestyle factors influence baseline NAD+ levels.

← All articles